✦ LIBER ✦

p38 MAP kinase inhibitors. Part 6: 2-Arylpyridazin-3-ones as templates for inhibitor design

✍ Scribed by Swaminathan R. Natarajan; Stephen T. Heller; Kiyean Nam; Suresh B. Singh; Giovanna Scapin; Sangita Patel; James E. Thompson; Catherine E. Fitzgerald; Stephen J. O’Keefe

Book ID: 108074143
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 320 KB
Volume: 16
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2006.08.074

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synthesis and biological activity of pyr

Synthesis and biological activity of pyridopyridazin-6-one p38α MAP kinase inhibitors. Part 2

✍ Tynebor, Robert M.; Chen, Meng-Hsin; Natarajan, Swaminathan R.; O’Neill, Edward 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 481 KB

SAR of 2,6-Diamino-3,5-difluoropyridinyl

SAR of 2,6-Diamino-3,5-difluoropyridinyl Substituted Heterocycles as Novel p38 MAP Kinase Inhibitors

✍ Laszlo Revesz; Franco E. Di Padova; Thomas Buhl; Roland Feifel; Hermann Gram; Pe 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 30 KB 👁 1 views

Synthesis and biological activity of pyr

Synthesis and biological activity of pyridopyridazin-6-one p38 MAP kinase inhibitors. Part 1

✍ Robert M. Tynebor; Meng-Hsin Chen; Swaminathan R. Natarajan; Edward A. O’Neill; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 705 KB

The development and synthesis of potent p38α MAP kinase inhibitors containing a pyridazinone platform is described. Evolution of the p38α selective pyridopyridazin-6-one series from the p38α/β dual inhibitor 2H-quinolizin-2-one series will be discussed in full detail.

2-Acylaminopyridin-4-ylimidazoles as p38

2-Acylaminopyridin-4-ylimidazoles as p38 MAP Kinase Inhibitors: Design, Synthesis, and Biological and Metabolic Evaluations

✍ Katharina Ziegler; Dominik R. J. Hauser; Anke Unger; Wolfgang Albrecht; Stefan A 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 369 KB 👁 1 views

p38 MAP Kinase Inhibitors. Part 1. Desig

p38 MAP Kinase Inhibitors. Part 1. Design and Development of a New Class of Potent and Highly Selective Inhibitors Based on 3,4-Dihydropyrido[3,2-d]pyrimidone Scaffold.

✍ Swaminathan R. Natarajan; et al. et al. 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 185 KB 👁 2 views

p38 MAP kinase inhibitors. Part 3: SAR o

p38 MAP kinase inhibitors. Part 3: SAR on 3,4-dihydropyrimido[4,5-d]pyrimidin-2-ones and 3,4-dihydropyrido[4,3-d]pyrimidin-2-ones

✍ Swaminathan R. Natarajan; David D. Wisnoski; James E. Thompson; Edward A. O’Neil 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 118 KB